Skip to search formSkip to main contentSkip to account menu

Gefarnate

Known as: Gefarnate [Chemical/Ingredient], 4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester, (E,E,E)-, Farnesylacetate, Geranyl 
A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Objectives To evaluate if esomeprazole prevents recurrent peptic ulcer in adult patients with a history of peptic ulcer receiving… 
2002
2002
Geranyl farnesylacetate (gefarnate) has been used to stimulate mucin production from goblet cells of patients who have gastritis… 
1998
1998
AIMS The effects of three drugs for the treatment of gastritis and gastric ulcer—gefarnate, ecabet sodium, and troxipide—on… 
1997
1997
The effect of drugs for gastritis and gastric ulcer (ecabet sodium, gefarnate, teprenone, and troxipide) on the secretion of… 
Highly Cited
1985
Highly Cited
1985
  • N. HaraS. Okabe
  • 1985
  • Corpus ID: 38011125
The effects of gefarnate on several acute gastric lesions were studied in rats. Gefarnate, given at either 100 approximately 1000… 
Review
1985
Review
1985
SummarySynopsis: Pirenzepine1 is a ‘selective’ tantimuscarinic agent which, unlike classic anticholinergic agents, inhibits… 
Highly Cited
1981
Highly Cited
1981
Antinuclear effects of geranylgeranylacetone (GGA), new acyclic polyisoprenoid, on several types of experimental gastric and… 
1973
1973
In 68 patients with chronic gastric ulcer treated in an outpatient clinical trial with either carbenoxolone or gefarnate ulcer…